QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online September 18, 2007
doi: 10.1242/10.1242/jcs.010389

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donninger, H. Articles by Clark, G. J. Search for Related Content PubMed PubMed Citation Articles by Donninger, H. Articles by Clark, G. J. Social Bookmarking                         What's this?

The RASSF1A tumor suppressor

¹ Molecular Targets Group, Department of Medicine, J. G. Brown Cancer Center, University of Louisville, 119C Baxter Boulevard, 580 S. Preston Street, Louisville, KY 40202, USA
² Research Analysis and Evaluation Branch, NCI, Rockville, MD, USA

^* Author for correspondence (e-mail: gjclar01{at}louisville.edu)

Accepted 23 July 2007

RASSF1A (Ras association domain family 1 isoform A) is a recently discovered tumor suppressor whose inactivation is implicated in the development of many human cancers. Although it can be inactivated by gene deletion or point mutations, the most common contributor to loss or reduction of RASSF1A function is transcriptional silencing of the gene by inappropriate promoter methylation. This epigenetic mechanism can inactivate numerous tumor suppressors and is now recognized as a major contributor to the development of cancer.

RASSF1A lacks apparent enzymatic activity but contains a Ras association (RA) domain and is potentially an effector of the Ras oncoprotein. RASSF1A modulates multiple apoptotic and cell cycle checkpoint pathways. Current evidence supports the hypothesis that it serves as a scaffold for the assembly of multiple tumor suppressor complexes and may relay pro-apoptotic signaling by K-Ras.

Key words: Epigenetic, RASSF1A, Ras, Tumor suppressor

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. F. Calvisi, H. Donninger, M. D. Vos, M. J. Birrer, L. Gordon, V. Leaner, and G. J. Clark NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53 Cancer Res., June 1, 2009; 69(11): 4629 - 4637. [Abstract] [Full Text] [PDF]

				J. Avruch, R. Xavier, N. Bardeesy, X.-f. Zhang, M. Praskova, D. Zhou, and F. Xia Rassf Family of Tumor Suppressor Polypeptides J. Biol. Chem., April 24, 2009; 284(17): 11001 - 11005. [Abstract] [Full Text] [PDF]

				S. Thaler, P. S. Hahnel, A. Schad, R. Dammann, and M. Schuler RASSF1A Mediates p21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of Akt Cancer Res., March 1, 2009; 69(5): 1748 - 1757. [Abstract] [Full Text] [PDF]

				D. Macheiner, C. Gauglhofer, C. Rodgarkia-Dara, M. Grusch, A. Brachner, C. Bichler, D. Kandioler, H. Sutterluty, W. Mikulits, R. Schulte-Hermann, et al. NORE1B Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF1A Cancer Res., January 1, 2009; 69(1): 235 - 242. [Abstract] [Full Text] [PDF]

				S. Hoare, K. Hoare, M. K. Reinhard, Y. J. Lee, S. P. Oh, and W. S. May Jr. Tnk1/Kos1 Knockout Mice Develop Spontaneous Tumors Cancer Res., November 1, 2008; 68(21): 8723 - 8732. [Abstract] [Full Text] [PDF]

				Y. Hao, A. Chun, K. Cheung, B. Rashidi, and X. Yang Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP J. Biol. Chem., February 29, 2008; 283(9): 5496 - 5509. [Abstract] [Full Text] [PDF]